DNA synthesis
Telesis Bio, Beckman Coulter Life Sciences Partner on DNA Synthesis Biofoundries
The deal brings together Telesis Bio's Gibson SOLA enzymatic DNA synthesis technology with Beckman Coulter's automation platform for rapid oligo production.
Evonetix Inks Deal With Analog Devices to Expand Thermally Controlled Enzymatic DNA Synthesis
The companies have signed a joint development and a commercial supply agreement to develop a semiconductor-based gene synthesis benchtop platform.
The synbio firm said its new enzymatic technology improves the quality and speed of DNA synthesis but has not revealed much of its manufacturing process.
Camena Bioscience Closes $10M Series A Financing Round
The UK-based synthetic biology startup said it will use the funding to scale its operations and to further develop its gSynth enzymatic DNA synthesis platform.
Evonetix Raises $24M in Extended Series B Funding Round
The company has now raised over $54 million in total Series B funding and has launched an early-access program for its DNA synthesis technology.